Cargando…
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
BACKGROUND: Monoclonal antibodies (mABs) targeting the calcitonin gene-related peptide (CGRP) pathway represent the first disease-specific preventive migraine therapy. Growing evidence suggests that they are effective in the preventive treatment of difficult-to-treat patients. In this study, we eval...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Milan
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487575/ https://www.ncbi.nlm.nih.gov/pubmed/34600468 http://dx.doi.org/10.1186/s10194-021-01333-4 |